Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features

BACKGROUND: Risk of prostate cancer-specific mortality (PCSM) is highly variable for men with adverse pathologic features at radical prostatectomy (RP); a majority will die of other causes. Accurately stratifying PCSM risk can improve therapy decisions. OBJECTIVE: Validate the 22 gene Decipher genom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Karnes, Robert Jeffrey, Choeurng, Voleak, Ross, Ashley E., Schaeffer, Edward M., Klein, Eric A., Freedland, Stephen J., Erho, Nicholas, Yousefi, Kasra, Takhar, Mandeep, Davicioni, Elai, Cooperberg, Matthew R., Trock, Bruce J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632569/
https://ncbi.nlm.nih.gov/pubmed/28400167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2017.03.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados